z-logo
open-access-imgOpen Access
Fibroblast‐Derived Induced Pluripotent Stem Cells Show No Common Retroviral Vector Insertions
Author(s) -
Varas Florencio,
Stadtfeld Matthias,
de AndresAguayo Luisa,
Maherali Nimet,
di Tullio Alessandro,
Pantano Lorena,
Notredame Cedric,
Hochedlinger Konrad,
Graf Thomas
Publication year - 2009
Publication title -
stem cells
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.159
H-Index - 229
eISSN - 1549-4918
pISSN - 1066-5099
DOI - 10.1634/stemcells.2008-0696
Subject(s) - biology , reprogramming , induced pluripotent stem cell , sox2 , klf4 , gene , genetics , microbiology and biotechnology , embryonic stem cell
Several laboratories have reported the reprogramming of mouse and human fibroblasts into pluripotent cells, using retroviruses carrying the Oct4 , Sox2 , Klf4 , and c‐Myc transcription factor genes. In these experiments the frequency of reprogramming was lower than 0.1% of the infected cells, raising the possibility that additional events are required to induce reprogramming, such as activation of genes triggered by retroviral insertions. We have therefore determined by ligation‐mediated polymerase chain reaction (LM‐PCR) the retroviral insertion sites in six induced pluripotent stem (iPS) cell clones derived from mouse fibroblasts. Seventy‐nine insertion sites were assigned to a single mouse genome location. Thirty‐five of these mapped to gene transcription units, whereas 29 insertions landed within 10 kilobases of transcription start sites. No common insertion site was detected among the iPS clones studied. Moreover, bioinformatics analyses revealed no enrichment of a specific gene function, network, or pathway among genes targeted by retroviral insertions. We conclude that Oct4, Sox2, Klf4, and c‐Myc are sufficient to promote fibroblast‐to‐iPS cell reprogramming and propose that the observed low reprogramming frequencies may have alternative explanations. S TEM C ELLS 2009;27:300–306

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here